发明申请
- 专利标题： Heterocyclic inhibitors of MEK and methods of use thereof
- 专利标题（中）： MEK的杂环抑制剂及其使用方法
-
申请号： US10992479申请日： 2004-11-18
-
公开(公告)号： US20050153942A1公开(公告)日： 2005-07-14
- 发明人: Eli Wallace , Jeongbeob Seo , Joseph Lyssikatos , Hong Yang , T. Hurley , Allison Marlow , James Blake
- 申请人： Eli Wallace , Jeongbeob Seo , Joseph Lyssikatos , Hong Yang , T. Hurley , Allison Marlow , James Blake
- 主分类号： A01N33/02
- IPC分类号： A01N33/02 ; A01N43/42 ; A01N43/54 ; A01N43/58 ; A01N43/60 ; A01N43/64 ; A01N43/90 ; A61K20060101 ; A61K31/40 ; A61K31/415 ; A61K31/416 ; A61K31/44 ; A61K31/4439 ; A61K31/4745 ; A61K31/495 ; A61K31/50 ; A61K31/501 ; A61K31/502 ; A61K31/517 ; A61K31/519 ; A61K31/53 ; A61K31/655 ; C07D20060101 ; C07D209/44 ; C07D209/46 ; C07D213/80 ; C07D213/82 ; C07D215/48 ; C07D221/04 ; C07D231/56 ; C07D237/24 ; C07D237/26 ; C07D237/28 ; C07D237/32 ; C07D239/74 ; C07D401/04 ; C07D401/06 ; C07D403/02 ; C07D413/02 ; C07D413/04 ; C07D413/14 ; C07D417/02 ; C07D417/04 ; C07D471/02 ; C07D471/04 ; C07D487/02 ; C07D491/02 ; C07D498/02
摘要：
Disclosed are compounds of the Formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, R7, R8 and R9, W, X, Y and Z are as defined in the specification. Such compounds are MEK inhibitors and are useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
公开/授权文献
- US07576072B2 Heterocyclic inhibitors of MEK and methods of use thereof 公开/授权日：2009-08-18
信息查询
